Form D · Biotechnology
Zeo ScientifiX, Inc.
Davie, FL · CIK 0001557376
Offering snapshot reported Dec 5, 2025 · SEC filing
- Reported sold
- $500K Offering amount: $5M
- Investors reported
- 2 Form D · investor count
- Minimum accepted
- $100K Reported outside-investor minimum
- First sale
- Nov 30, 2025 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Dec 5, 2025 | Initial | $500,000 | No comparison | 2 | SEC filing |
| Jul 16, 2024 | Initial | $500,000 | No comparison | 1 | SEC filing |
| Aug 25, 2023 | Initial | $350,000 | No comparison | 2 | SEC filing |
| Aug 16, 2021 | Initial | $500,000 | No comparison | Not reported | SEC filing |
| Jun 30, 2015 | Initial | $25,000 | No comparison | 1 | SEC filing |
Offering details
- Securities
- Equity, Option to acquire, Security to be acquired
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-565974
Source: Form D, filed Dec 5, 2025. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Ian T. Bothwell | Director, Executive |
| Chuck Bretz | Director |
| Michael Carbonara | Director |
| S. Jerry Glauser | Director |
| Dr. Howard L. Golub | Executive |
| John Goodhew | Director |
| Dr. Harry Leider | Director, Executive |
| Allen Meglin | Director |
| Albert Mitrani | Director, Executive |
| Maria Ines Mitrani | Director, Executive |
| Dr. George Shapiro | Director, Executive |
| George Shapiro | Director, Executive |
| Gurvinder Pal Singh | Director |
| Leathem Stearn | Director |
Issuer details
Industry: Biotechnology (See others in industry)
Address:
3321 College Avenue Suite 246
Davie, FL, 33314
Davie, FL, 33314